论文部分内容阅读
目的探求治疗中晚期肝癌的有效方法。方法选择56例中晚期肝癌患者随机分两组进行前瞻性对比治疗研究。治疗组31例，用平消胶囊联合介入栓塞化疗（TAE）术，对照组25例单用TAE术。结果治疗组和对照组有效率（CR＋PR）分别为80．64％、68％（P＜0．05），进展率（PD）分别为0％和8％（P＜0．001），治疗前后症状改善率分别为80．64％和64％（P＜0．05），AKP变化也有显著差异。毒副反应治疗组校对照组明显少而轻。结论平消胶囊联合TAE术，治疗中晚期肝癌具有协同作用，疗效明显，值得推广应用。
Objective To explore effective methods for the treatment of advanced liver cancer. Methods 56 patients with advanced liver cancer were randomly divided into two groups for prospective comparative treatment. In the treatment group, 31 patients were treated with Pingxiao capsule combined with interventional embolization chemotherapy (TAE), and 25 patients in the control group were treated with TAE alone. Results The effective rate (CR+PR) of the treatment group and the control group was 80.64% and 68% (P<0.05), and the progression rate (PD) was 0% and 8%, respectively (P<0.001). The improvement rate of symptoms was 80.64% and 64% (P<0.05), and the AKP changes were also significantly different. The toxicity control group was significantly less and lighter than the control group. Conclusion Pingxiao capsule combined with TAE has a synergistic effect on the treatment of advanced hepatocellular carcinoma. The curative effect is obvious and worthy of popularization and application.